A citation-based method for searching scientific literature

Anna F Farago, Long P Le, Zongli Zheng, Alona Muzikansky, Alexander Drilon, Manish Patel, Todd M Bauer, Stephen V Liu, Sai-Hong I Ou, David Jackman, Daniel B Costa, Pratik S Multani, Gary G Li, Zachary Hornby, Edna Chow-Maneval, David Luo, Jonathan E Lim, Anthony J Iafrate, Alice T Shaw. J Thorac Oncol 2015
Times Cited: 144



Kengo Takeuchi, Manabu Soda, Yuki Togashi, Ritsuro Suzuki, Seiji Sakata, Satoko Hatano, Reimi Asaka, Wakako Hamanaka, Hironori Ninomiya, Hirofumi Uehara, Young Lim Choi, Yukitoshi Satoh, Sakae Okumura, Ken Nakagawa, Hiroyuki Mano, Yuichi Ishikawa. Nat Med 2012
Times Cited: 843




List of shared articles



Times cited

An improved assay for detection of theranostic gene translocations and MET exon 14 skipping in thoracic oncology.
Nicolas Piton, Marie-Delphine Lanic, Florent Marguet, Aude Lamy, France Blanchard, Florian Guisier, Mathieu Viennot, Mathieu Salaün, Luc Thiberville, Fabrice Jardin,[...]. Lab Invest 2021
0

Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET).
Shinji Takeuchi, Noriko Yanagitani, Takashi Seto, Yoshihiro Hattori, Kadoaki Ohashi, Masahiro Morise, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto, Makoto Nishio,[...]. Transl Lung Cancer Res 2021
1

Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake.
Alessandro De Toma, Giuseppe Lo Russo, Diego Signorelli, Filippo Pagani, Giovanni Randon, Giulia Galli, Arsela Prelaj, Roberto Ferrara, Claudia Proto, Monica Ganzinelli,[...]. Crit Rev Oncol Hematol 2021
0


[Fusion transcripts: Therapeutic targets in thoracic oncology].
Audrey Mansuet-Lupo, Simon Garinet, Diane Damotte, Marco Alifano, Hélène Blons, Marie Wislez, Karen Leroy. Bull Cancer 2020
0

Molecular Pathology of Primary Non-small Cell Lung Cancer.
David Ilan Suster, Mari Mino-Kenudson. Arch Med Res 2020
3

RET Fusion: Joining the Ranks of Targetable Molecular Drivers in NSCLC.
Badi El Osta, Suresh S Ramalingam. JTO Clin Res Rep 2020
0

Somatic mutations and immune checkpoint biomarkers.
Brielle A Parris, Eloise Shaw, Brendan Pang, Richie Soong, Kwun Fong, Ross A Soo. Respirology 2019
3

Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: a short review on the current evidence.
Biagio Ricciuti, Carlo Genova, Lucio Crinò, Massimo Libra, Giulia Costanza Leonardi. Onco Targets Ther 2019
22

The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancer.
Aniello Cerrato, Roberta Visconti, Angela Celetti. Mol Cancer 2018
10


Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples.
Kurtis D Davies, Anh T Le, Jamie Sheren, Hala Nijmeh, Katherine Gowan, Kenneth L Jones, Marileila Varella-Garcia, Dara L Aisner, Robert C Doebele. J Thorac Oncol 2018
71

Emerging targets in advanced non-small-cell lung cancer.
Francesco Valentino, Gloria Borra, Paolo Allione, Lorena Rossi. Future Oncol 2018
11


RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients.
Shumei Kato, Vivek Subbiah, Erica Marchlik, Sheryl K Elkin, Jennifer L Carter, Razelle Kurzrock. Clin Cancer Res 2017
90